Abstract. In the last 5 years, there has been only one reported human case of West Nile virus (WNV) disease in northern Mexico. To determine if the virus was still circulating in this region, equine and entomological surveillance for WNV was conducted in the state of Nuevo Leon in northern Mexico in 2006 and 2007. A total of 203 horses were serologically assayed for antibodies to WNV using an epitope-blocking enzyme-linked immunosorbent assay (bELISA). Seroprevalences for WNV in horses sampled in 2006 and 2007 were 26% and 45%, respectively. Mosquito collections in 2007 produced 7365 specimens representing 15 species. Culex mosquitoes were screened for WNV RNA and other genera (Mansonia, Anopheles, Aedes, Psorophora and Uranotaenia) were screened for flaviviruses using reversetranscription (RT)-PCR. Two pools consisting of Culex spp. mosquitoes contained WNV RNA. Molecular species identification revealed that neither pool included Culex quinquefasciatus (Say) (Diptera:Culicidae) complex mosquitoes. No evidence of flaviviruses was found in the other mosquito genera examined. These data provide evidence that WNV is currently circulating in northern Mexico and that non-Cx. quinquefasciatus spp. mosquitoes may be participating in the WNV transmission cycle in this region.
Introduction
West Nile virus (WNV; Flaviviridae, Flavivirus) is a member of the Japanese encephalitis complex, which also includes Japanese encephalitis virus, St. Louis encephalitis virus (SLEV) and Murray Valley encephalitis virus (Heinz et al., 2000) . The virus is transmitted in natural cycles that primarily involve Culex spp. mosquitoes and birds (Hayes, 1988; Burke & Monath, 2001 ). Humans and horses can develop clinical illness after WNV infections but are considered dead-end hosts for virus transmission (Hayes, 1988; Roehrig et al., 2002) .
Correspondence: Luis Ibarra Juarez, Facultad de Ciencias Biológicas, Universidad Autonoma de Nuevo León, San Nicolás de los Garza, Nuevo León, CP 66451, México. Tel./Fax: +52 81 8332 1453; E-mail: mvzibarra60@hotmail.com The initial outbreak of WNV in North America occurred in New York City in 1999 and WNV has subsequently spread throughout the Americas (Lanciotti et al., 1999; Gould & Fikrig, 2004; Cruz et al., 2005; Mattar et al., 2005) . In the U.S.A., annual numbers of reported WNV disease cases during 2002 to 2008 ranged from 1356 to 9862 (http://www. cdc.gov/ncidod/dvbid/westnile/ surv&control.htm). The first evidence of WNV activity in northern Mexico occurred in 2002 when antibodies to WNV were detected in horses in the states of Coahuila, Chihuahua and Tamaulipas (Blitvich et al., 2003a; Estrada et al., 2003) . Serological evidence of WNV activity has now been reported in almost every Mexican state (Komar & Clark, 2006; Blitvich, 2008) . However, only eight human cases of WNV disease have been reported in Mexico. These cases occurred in the states of Chihuahua (n = 4), Sonora (n = 1) and Nuevo Leon (n = 1) in 2003, Sonora (n = 1) in 2004 and Nuevo Leon (n = 1) in 2009 (Elizondo Quiroga et al., 2005; Komar & Clark, 2006; Blitvich, 2008; Rios-Ibarra et al., 2010) .
Several species of mosquitoes have been reported to be infected with WNV in Mexico, including Culex nigripalpus (Theobald) and Cx. interrogator (Dyar and Knab) in Chiapas State, Cx. tarsalis (Coquillett) in Baja California State, and Cx. quinquefasciatus (Say) in Nuevo Leon State (Elizondo et al., 2005; Medina et al., 2008; Ulloa et al., 2009) . However, there has been very limited success in obtaining isolates of WNV from any source in Mexico (Estrada et al., 2003; Blitvich et al., 2004; Elizondo et al., 2005; Deardorff et al., 2006 
Materials and methods
Serum samples were collected from 203 available selected horses in every locality. Of these, 62 horses were sampled from April to August 2006, and 141 horses were sampled in September and October 2007. None of the horses had been vaccinated against WNV or had any travel history. Additionally, all were asymptomatic at the time of sampling. Serum samples were screened at the Universidad Autonoma de Nuevo Leon (UANL) for antibodies to WNV using an epitopeblocking enzyme-linked immunosorbent assay (bELISA) as previously described (Blitvich et al., 2003b,c) . The ELISA was performed with WNV-specific monoclonal antibody (MAb) 3.1112G (Vector Laboratories, Burlingame, CA, U.S.A.). The ability of the horse serum to block the binding of MAb to WNV antigen was compared with the blocking ability of horse serum without antibody to WNV. Data were expressed as relative percentages, and inhibition values ≥30% were considered to indicate viral antibodies (Blitvich et al., 2003b,c Mosquito pools were triturated for 45 s with a vortex mixer in a 5-mL round-bottom polypropylene tube (Becton Dickinson, Franklin Lakes, New Jersey, U.S.A.) that contained 1.5 mL of diluent (1× minimum essential medium supplemented with 2% fetal bovine serum, penicillin/streptomycin, L-glutamine and non-essential amino acids) and four coppercoated steel shot (4.5-mm diameter; 0.177 caliber). Suspensions were centrifuged at 12,000 g for 10 min at 4
• C, and supernatants were collected. Total RNA was extracted from supernatants using the QIAamp viral RNA Mini kit (Qiagen Inc., Valencia, California, U.S.A.). All non-Culex spp. mosquitoes were analysed by RT-PCR using previously described flavivirus-specific primers (Scaramozzino et al., 2001) . Mosquito pools with Culex spp. mosquitoes were tested using WNV-specific primers developed and recommended by the United States Centers for Disease Control and Prevention for use in WNV surveillance (Gubler et al., 2000; Lanciotti et al., 2000) . Complementary DNAs were generated using Superscript III reverse transcriptase (Invitrogen, Carlsbad, California, U.S.A.) and PCRs were performed using GoTaq DNA polymerase (Promega, Madison, WI, U.S.A.). PCR products were purified using the QIAquick Gel Extraction Kit (Qiagen Inc.) and sequenced at the CSU Proteomics and Metabolomics Facility which uses the Applied Biosystems 3130 Genetic Analyzer (Applied Biosystems, Foster City, California, U.S.A.).
Results and Discussion
Eighty-three (41%) horses had antibodies to WNV by bELISA. Of the 62 horses sampled in 2006, 16 (26%) were seropositive for WNV. Of the 141 horses sampled in 2007, 67 (48%) had evidence of WNV exposure. Rates of WNV exposure were compared by sex and age using the SAS 9.1 statistical software package (SAS Institute Inc., Cary, NC). There were no significant differences in the seroprevalence for WNV in female and male horses in 2006 (27% of 37 females vs. 20% of 25 males with evidence of WNV exposure; χ 2 = 1.36, P = 0.24) or in 2007 (50% of 54 females vs. 46% of 87 males with evidence of WNV exposure; χ 2 = 0.32, P = 0.57). However, there were significant differences in the seroprevalence for WNV in horses <10 years and >10 years in 2006 (25% of 61 younger horses vs. 0% of 1 older horses with evidence of WNV exposure; χ 2 = 28.57, P < 0.001) and 2007 (51% of 119 younger horses vs. 27% of 22 older horses with evidence of WNV exposure; χ 2 = 12.11, P < 0.001). The youngest seropositive horse was a 12-month-old colt sampled in Cadereyta in October 2007 suggesting that the most recent WNV infection occurred in late 2006 or in 2007.
A total of 3238 Culex mosquitoes were screened using RT-PCR with WNV-specific primers. WNV RNA was detected in two pools consisting of Culex spp. mosquitoes (Minimum Infection Rate per 1000 Culex mosquitoes = 0.61). Sequencing of the PCR products (GenBank accessions GQ862373 and GQ862374) revealed that they are identical to the homologous regions of multiple isolates from both the NY99 or WN02 genotypes and thus, we could not identify the WNV genotype responsible for these infections. The mosquitoes in these two pools could not be identified to species based on morphological characteristics and therefore we attempted to determine their identity using a molecular species identification technique. Briefly, genomic DNA was extracted from the mosquito pools using the Qiagen DNeasy blood and tissue kit (Qiagen Inc.) and analysed by PCR using previously described Cx. quinquefasciatus complex-specific primers (Aspen et al., 2003) (Blitvich et al., 2003a; Marlenee et al., 2004; Farfan-Ale et al., 2006; Alonso-Padilla et al., 2009) . WNV RNA was detected in two pools of Culex mosquitoes in Nuevo Leon State in 2007. Unfortunately, both mosquito pools containing WNV RNA were comprised of Culex spp. mosquitoes. Using a molecular species identification technique, it was determined that these pools did not contain Cx. quinquefasciatus or Cx. pipiens. This is important because Cx. quinquefasciatus was found to be infected with WNV in a previous study in Nuevo Leon (Elizondo et al., 2005) . Additionally, Cx. quinquefasciatus is the principle vector of WNV in neighbouring Texas (Lillibridge et al., 2004; Vanlandingham et al., 2007) . Other Culex species collected in the present study, and thus likely to be represented in the Culex spp. pools, included Cx. erraticus and Cx. coronator. Both species have been reported to be naturally infected with WNV in the U.S.A. (http://www.cdc.gov/ncidod/dvbid/westnile/mosquitoSpecies. htm#99). Furthermore, Ulloa et al. (2009) detected WNV in pools of Cx. nigripalpus and Cx. interrogator from Chiapas State in southern Mexico, and Medina et al. (2008) reported WNV in Cx. tarsalis from Baja California State in northwestern Mexico. None of these three species were collected in the present study. Further studies on Culex mosquitoes in different parts of Mexico are needed to determine which species potentially serve as locally important WNV vectors to humans and domestic animals. Indeed, much remains to be discovered in northern Mexico about enzootic WNV transmission cycles, including determination of locally important mosquito vectors and microhabitats where humans and horses are at an elevated risk of exposure to WNV-infected mosquitoes.
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